Pingping Li
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, 100142, China
Beijing, 100142, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting the CXCR7 pathway with TC14012 to inhibit endothelial necroptosis and lung cancer metastasis.
Journal: Biochemical pharmacology
Published: November 22, 2024
HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer.
Journal: Cell death discovery
Published: January 21, 2023
Modified Bu-Fei decoction inhibits lung metastasis via suppressing angiopoietin-like 4.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 24, 2022
Marsdenia tenacissima extract promotes gefitinib accumulation in tumor tissues of lung cancer xenograft mice via inhibiting ABCG2 activity.
Journal: Journal of ethnopharmacology
Published: January 05, 2020
Macrophage deletion of Noc4l triggers endosomal TLR4/TRIF signal and leads to insulin resistance.
Journal: Nature communications
Published: April 26, 2019
Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Journal: International journal of oncology
Published: January 09, 2017
Progress in Palliative Care Benefit of Elderly Patients with Non-small Cell Lung Cancer
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: July 18, 2015
Comprehensive geriatric assessment and traditional Chinese medicine intervention benefit symptom control in elderly patients with advanced non-small cell lung cancer.
Journal: Medical oncology (Northwood, London, England)
Published: March 01, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026